Despite in-line EPS and improved net loss, the significant revenue miss and declining case volume signal ongoing operational weakness. The 2026 guidance implies no growth, suggesting continued headwinds. Traders should monitor same-store sales trends and cost management in 2026; recent ATM offering adds dilution risk.
Price Chart
Executive Summary
Airsculpt Technologies (AIRS) reported Q4 and full-year 2025 results with revenue and EPS in line with consensus, but declining YoY. Revenue fell 14.6% in Q4 and 15.8% for the full year, driven by lower case volume. The company guided 2026 revenue of $151M–$157M and adjusted EBITDA of $15M–$17M, signaling stabilization. Despite a net loss improvement, Adjusted EBITDA declined sharply due to London closure costs and impairments.
Key Financial Metrics
Key Facts
- Q4 2025 revenue of $33.4M, down 14.6% YoY vs. consensus of $39.0M
- EPS of $-0.02, in line with analyst estimate
- Full-year 2025 revenue declined 15.8% to $151.8M
- Case volume down 15.0% in Q4 and 15.6% for full year
- Adjusted EBITDA of $(0.1)M in Q4 vs. $1.9M in prior year
- Full-year 2025 Adjusted EBITDA dropped to $12.5M from $21.0M
- Guided 2026 revenue of $151M–$157M and Adjusted EBITDA of $15M–$17M
- Raised $14.8M via ATM, reduced debt to $45.0M
Financial Impact
Revenue down $5.8M below consensus, full-year Adjusted EBITDA down $8.5M YoY
Risk Factors
- Continued decline in case volume and same-store sales
- Execution risk in new go-to-market strategy
- Dilution from recent ATM offering
- Exposure to GLP-1 drug competition in weight-loss market
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3268319 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 15, 2026 10w ago | Institutional Cluster | $3.09 $2.13 | ▼ −30.96% | ▼ −28.98% | $1.27 (−58.83%) |
Aug 10, 2026 11w ago | 8-K | $2.75 $2.71 | ▲ +1.64% | ▲ +0.72% | $1.27 (+53.82%) |
Aug 10, 2026 11w ago | Press Release | $2.75 $2.71 | ▲ +1.64% | ▲ +0.72% | $1.27 (+53.82%) |
May 8, 2026 24w ago | 8-K | $3.86 $5.11 | ▲ +32.38% | ▲ +32.36% | $1.27 (−67.10%) |
May 8, 2026 24w ago | Press Release | $3.86 $5.11 | ▼ −32.38% | ▼ −32.36% | $1.27 (+67.10%) |
May 1, 2026 25w ago | Press Release | $3.32 $5.30 | ▲ +59.64% | ▲ +54.35% | $1.27 (−61.75%) |
Apr 6, 2026 29w ago | 10-K/A | $3.10 $3.44 | ▼ −10.97% | ▼ −1.98% | $1.27 (+59.03%) |
Apr 6, 2026 29w ago | Press Release | $3.10 $3.44 | ▼ −10.97% | ▼ −1.98% | $1.27 (+59.03%) |
Apr 2, 2026 29w ago | 8-K | $3.17 $2.68 | ▲ +15.46% | ▲ +25.33% | $1.27 (+59.94%) |
Apr 2, 2026 29w ago | Press Release | $3.17 $2.68 | ▲ +15.46% | ▲ +25.33% | $1.27 (+59.94%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers